GLOBAL TOBRAMYCIN EYE DROP MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Tobramycin Eye Drop Market, By Type (Tobramycin and Dexamethasone Suspension, Tobramycin Suspension, Others Tobramycin Combinations), By Indication (Bacterial Eye Infections, Keratitis, Pre-/post-ocular Surgery Prophylaxis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In April 2019, Alembic Pharmaceuticals Limited, a pharmaceutical company, announced that it had received an approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) Tobramycin Ophthalmic Solution USP, 0.3%. Tobramycin Ophthalmic Solution USP, 0.3% is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria.

Global Tobramycin Eye Drop Market Report Snapshots